BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matoori S, Leroux JC. Recent advances in the treatment of hyperammonemia. Adv Drug Deliv Rev 2015;90:55-68. [PMID: 25895618 DOI: 10.1016/j.addr.2015.04.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Moedas M, Adam A, Farelo M, Ijlst L, Chamuleau R, Hoekstra R, Wanders R, Silva M. Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS. Analytical Biochemistry 2017;535:47-55. [DOI: 10.1016/j.ab.2017.07.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
2 Gioia R, Tonelli F, Ceppi I, Biggiogera M, Leikin S, Fisher S, Tenedini E, Yorgan TA, Schinke T, Tian K, Schwartz JM, Forte F, Wagener R, Villani S, Rossi A, Forlino A. The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta. Hum Mol Genet 2017;26:2897-911. [PMID: 28475764 DOI: 10.1093/hmg/ddx171] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 10.5] [Reference Citation Analysis]
3 Agostoni V, Lee SH, Forster V, Kabbaj M, Bosoi CR, Tremblay M, Zadory M, Rose CF, Leroux J. Liposome-Supported Peritoneal Dialysis for the Treatment of Hyperammonemia-Associated Encephalopathy. Adv Funct Mater 2016;26:8382-9. [DOI: 10.1002/adfm.201603519] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
4 Giacalone G, Matoori S, Agostoni V, Forster V, Kabbaj M, Eggenschwiler S, Lussi M, De Gottardi A, Zamboni N, Leroux J. Liposome-supported peritoneal dialysis in the treatment of severe hyperammonemia: An investigation on potential interactions. Journal of Controlled Release 2018;278:57-65. [DOI: 10.1016/j.jconrel.2018.03.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
5 Diez-Fernandez C, Häberle J. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder. Expert Opin Ther Targets 2017;21:391-9. [PMID: 28281899 DOI: 10.1080/14728222.2017.1294685] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
6 Said VJ, Garcia-trujillo E. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy. Gastroenterology Nursing 2019;42:277-85. [DOI: 10.1097/sga.0000000000000376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kose E, Kuyum P, Aksoy B, Häberle J, Arslan N, Ozturk Y. First report of carglumic acid in a patient with citrullinemia type 1 (argininosuccinate synthetase deficiency). J Clin Pharm Ther 2018;43:124-8. [PMID: 28741715 DOI: 10.1111/jcpt.12593] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Zhang L, Leroux JC. Current and forthcoming approaches for systemic detoxification. Adv Drug Deliv Rev 2015;90:1-2. [PMID: 26298477 DOI: 10.1016/j.addr.2015.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
9 Wang Y, Chang L, Zhai J, Wu Q, Wang D, Wang Y. Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism. J Cell Mol Med 2017;21:3214-23. [PMID: 28557353 DOI: 10.1111/jcmm.13225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Pérez-Burillo S, Navajas-Porras B, López-Maldonado A, Hinojosa-Nogueira D, Pastoriza S, Rufián-Henares JÁ. Green Tea and Its Relation to Human Gut Microbiome. Molecules 2021;26:3907. [PMID: 34206736 DOI: 10.3390/molecules26133907] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Zhang S, Zhao Y, Ohland C, Jobin C, Sang S. Microbiota facilitates the formation of the aminated metabolite of green tea polyphenol (-)-epigallocatechin-3-gallate which trap deleterious reactive endogenous metabolites. Free Radic Biol Med 2019;131:332-44. [PMID: 30578921 DOI: 10.1016/j.freeradbiomed.2018.12.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
12 Fan L, Zhao J, Jiang L, Xie L, Ma J, Li X, Cheng M. Molecular, biochemical, and clinical analyses of five patients with carbamoyl phosphate synthetase 1 deficiency. J Clin Lab Anal 2020;34:e23124. [PMID: 31749211 DOI: 10.1002/jcla.23124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Spyrogianni A, Gourmel C, Hofmann L, Marbach J, Leroux JC. Optimization of an ammonia assay based on transmembrane pH-gradient polymersomes. Sci Rep 2021;11:22032. [PMID: 34764318 DOI: 10.1038/s41598-021-01137-1] [Reference Citation Analysis]
14 Brossier D, Goyer I, Ziani L, Marquis C, Mitchell G, Ozanne B, Jouvet P. Influence of implementing a protocol for an intravenously administered ammonia scavenger on the management of acute hyperammonemia in a pediatric intensive care unit. J Inherit Metab Dis. 2019;42:77-85. [PMID: 30740742 DOI: 10.1002/jimd.12029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kiykim E, Oguz O, Duman C, Zubarioglu T, Cansever MS, Zeybek ACA. Long-term N-carbamylglutamate treatment of hyperammonemia in patients with classic organic acidemias. Mol Genet Metab Rep 2021;26:100715. [PMID: 33552909 DOI: 10.1016/j.ymgmr.2021.100715] [Reference Citation Analysis]
16 López-Corella E, Ibarra-González I, Fernández-Lainez C, Rodríguez-Weber MÁ, Guillén-Lopez S, Belmont-Martínez L, Agüero-Linares D, Vela-Amieva M. Kernicterus in a boy with ornithine transcarbamylase deficiency: A case report. Neuropathology 2017;37:586-90. [PMID: 28815739 DOI: 10.1111/neup.12404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
17 Matoori S, Bao Y, Schmidt A, Fischer EJ, Ochoa-Sanchez R, Tremblay M, Oliveira MM, Rose CF, Leroux JC. An Investigation of PS-b-PEO Polymersomes for the Oral Treatment and Diagnosis of Hyperammonemia. Small 2019;15:e1902347. [PMID: 31721441 DOI: 10.1002/smll.201902347] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
18 Soria LR, Nitzahn M, De Angelis A, Khoja S, Attanasio S, Annunziata P, Palmer DJ, Ng P, Lipshutz GS, Brunetti-Pierri N. Hepatic glutamine synthetase augmentation enhances ammonia detoxification. J Inherit Metab Dis 2019;42:1128-35. [PMID: 30724386 DOI: 10.1002/jimd.12070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gaur H, Purushothaman S, Pullaguri N, Bhargava Y, Bhargava A. Sodium benzoate induced developmental defects, oxidative stress and anxiety-like behaviour in zebrafish larva. Biochem Biophys Res Commun 2018;502:364-9. [PMID: 29842881 DOI: 10.1016/j.bbrc.2018.05.171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
20 Liu J, Lkhagva E, Chung HJ, Kim HJ, Hong ST. The Pharmabiotic Approach to Treat Hyperammonemia. Nutrients 2018;10:E140. [PMID: 29382084 DOI: 10.3390/nu10020140] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
21 Ye Q, Yin W, Zhang L, Xiao H, Qi Y, Liu S, Qian B, Wang F, Han T. The value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis. PLoS One 2017;12:e0175165. [PMID: 28384211 DOI: 10.1371/journal.pone.0175165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
22 Malla CF, Mireles NA, Ramírez AS, Poveda JB, Tavío MM. Aspirin, sodium benzoate and sodium salicylate reverse resistance to colistin in Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother 2020;75:3568-75. [PMID: 32989461 DOI: 10.1093/jac/dkaa371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
23 Nasr DM, Hocker S, Wijdicks EFM. Organ Transplant Recipients and Critical Care Seizures. In: Varelas PN, Claassen J, editors. Seizures in Critical Care. Cham: Springer International Publishing; 2017. pp. 259-68. [DOI: 10.1007/978-3-319-49557-6_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Pratsinis A, Devuyst O, Leroux J. Peritoneal dialysis beyond kidney failure? Journal of Controlled Release 2018;282:3-12. [DOI: 10.1016/j.jconrel.2018.01.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Ribas GS, Lopes FF, Deon M, Vargas CR. Hyperammonemia in Inherited Metabolic Diseases. Cell Mol Neurobiol 2021. [PMID: 34665389 DOI: 10.1007/s10571-021-01156-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zacharias HD, Zacharias AP, Gluud LL, Morgan MY. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. Cochrane Database Syst Rev 2019;6:CD012334. [PMID: 31204790 DOI: 10.1002/14651858.CD012334.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
27 Meijer R, Vivekananda U, Balestrini S, Walker M, Lachmann R, Haeberle J, Murphy E. Ammonia: what adult neurologists need to know. Pract Neurol 2020:practneurol-2020-002654. [PMID: 33310884 DOI: 10.1136/practneurol-2020-002654] [Reference Citation Analysis]
28 Matoori S, Leroux J. Twenty-five years of polymersomes: lost in translation? Mater Horiz 2020;7:1297-309. [DOI: 10.1039/c9mh01669d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 11.5] [Reference Citation Analysis]
29 Soria LR, Allegri G, Melck D, Pastore N, Annunziata P, Paris D, Polishchuk E, Nusco E, Thöny B, Motta A, Häberle J, Ballabio A, Brunetti-Pierri N. Enhancement of hepatic autophagy increases ureagenesis and protects against hyperammonemia. Proc Natl Acad Sci U S A 2018;115:391-6. [PMID: 29279371 DOI: 10.1073/pnas.1714670115] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
30 Wu YF. Recurrent Hyperammonemia Associated With Olanzapine. J Clin Psychopharmacol 2017;37:366-7. [PMID: 28350574 DOI: 10.1097/JCP.0000000000000694] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
31 Tawfik P, Arndt P. Lethal hyperammonemia in a CAR-T cell recipient due to Ureaplasma pneumonia: a case report of a unique severe complication. BMJ Case Rep 2021;14:e242513. [PMID: 34244183 DOI: 10.1136/bcr-2021-242513] [Reference Citation Analysis]
32 Seethapathy H, Fenves AZ. Pathophysiology and Management of Hyperammonemia in Organ Transplant Patients. Am J Kidney Dis 2019;74:390-8. [PMID: 31040091 DOI: 10.1053/j.ajkd.2019.03.419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Besio R, Garibaldi N, Leoni L, Cipolla L, Sabbioneda S, Biggiogera M, Mottes M, Aglan M, Otaify GA, Temtamy SA, Rossi A, Forlino A. Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate. Dis Model Mech 2019;12:dmm038521. [PMID: 31171565 DOI: 10.1242/dmm.038521] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
34 Häberle J, Chakrapani A, Ah Mew N, Longo N. Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories. Orphanet J Rare Dis 2018;13:219. [PMID: 30522498 DOI: 10.1186/s13023-018-0963-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
35 Chapel-Crespo CC, Diaz GA, Oishi K. Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders. Expert Rev Endocrinol Metab 2016;11:467-73. [PMID: 30034506 DOI: 10.1080/17446651.2016.1239526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Long MT, Coursin DB. Undifferentiated non-hepatic hyperammonemia in the ICU: Diagnosis and management. J Crit Care 2022;70:154042. [PMID: 35447602 DOI: 10.1016/j.jcrc.2022.154042] [Reference Citation Analysis]
37 Savy N, Brossier D, Brunel-Guitton C, Ducharme-Crevier L, Du Pont-Thibodeau G, Jouvet P. Acute pediatric hyperammonemia: current diagnosis and management strategies. Hepat Med 2018;10:105-15. [PMID: 30254497 DOI: 10.2147/HMER.S140711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
38 Matoori S, Roveri M, Tiefenboeck P, Romagna A, Wuerthinger O, Kolokythas O, Froehlich JM. An MRI-guided HIFU-triggered wax-coated capsule for supertargeted drug release: a proof-of-concept study. Eur Radiol Exp 2019;3:11. [PMID: 30838465 DOI: 10.1186/s41747-019-0090-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zheng DW, Pan P, Chen KW, Fan JX, Li CX, Cheng H, Zhang XZ. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure. Nat Biomed Eng 2020;4:853-62. [PMID: 32632226 DOI: 10.1038/s41551-020-0582-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
40 Schmidt AC, Leroux J. Treatments of trimethylaminuria: where we are and where we might be heading. Drug Discovery Today 2020;25:1710-7. [DOI: 10.1016/j.drudis.2020.06.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
41 Zhang S, Wang R, Zhao Y, Tareq FS, Sang S. Metabolic Interaction between Ammonia and Baicalein. Chem Res Toxicol 2020;33:2181-8. [PMID: 32618193 DOI: 10.1021/acs.chemrestox.0c00205] [Reference Citation Analysis]
42 Lee JS, Jin HY, Ko JM, Kim SH, Han N, Park BK, Park M, Park HJ, Lee JA. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers. Cancer Res Treat 2021;53:283-8. [PMID: 32898940 DOI: 10.4143/crt.2020.575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Okamoto K, Nozawa H, Hongo K, Iida Y, Kawai K, Sasaki K, Murono K, Kita Y, Ishihara Y, Takabayashi N, Kobayashi R, Hiramatsu T, Ishihara S. Risk factors of mFOLFOX6-induced hyperammonemia in patients with colorectal cancer: an observational study. Int J Clin Oncol 2021;26:1477-84. [PMID: 33991268 DOI: 10.1007/s10147-021-01932-w] [Reference Citation Analysis]
44 Besio R, Iula G, Garibaldi N, Cipolla L, Sabbioneda S, Biggiogera M, Marini JC, Rossi A, Forlino A. 4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion. Biochim Biophys Acta Mol Basis Dis 2018;1864:1642-52. [PMID: 29432813 DOI: 10.1016/j.bbadis.2018.02.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
45 Garay RP, Citrome L, Samalin L, Liu C, Thomsen MS, Correll CU, Hameg A, Llorca P. Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries. Expert Opinion on Pharmacotherapy 2016;17:921-36. [DOI: 10.1517/14656566.2016.1149164] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
46 Bohner M, Maazouz Y, Ginebra M, Habibovic P, Schoenecker JG, Seeherman H, van den Beucken J, Witte F. Sustained local ionic homeostatic imbalance caused by calcification modulates inflammation to trigger heterotopic ossification. Acta Biomaterialia 2022. [DOI: 10.1016/j.actbio.2022.03.057] [Reference Citation Analysis]
47 Gambello MJ, Li H. Current strategies for the treatment of inborn errors of metabolism. J Genet Genomics 2018;45:61-70. [PMID: 29500085 DOI: 10.1016/j.jgg.2018.02.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
48 Matoori S, Forster V, Agostoni V, Bettschart-Wolfensberger R, Bektas RN, Thöny B, Häberle J, Leroux JC, Kabbaj M. Preclinical evaluation of liposome-supported peritoneal dialysis for the treatment of hyperammonemic crises. J Control Release 2020;328:503-13. [PMID: 32860926 DOI: 10.1016/j.jconrel.2020.08.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Häberle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, Mandel H, Martinelli D, Pintos-Morell G, Santer R, Skouma A, Servais A, Tal G, Rubio V, Huemer M, Dionisi-Vici C. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis 2019;42:1192-230. [PMID: 30982989 DOI: 10.1002/jimd.12100] [Cited by in Crossref: 93] [Cited by in F6Publishing: 76] [Article Influence: 31.0] [Reference Citation Analysis]
50 Angelo C, Vincent MF, Komuta M, Hantson P, Straetmans N, Boulet E. Fatal Idiopathic Hyperammonemia after Induction Chemotherapy for Acute Myeloid Leukemia. Case Rep Hematol 2020;2020:3136074. [PMID: 32089907 DOI: 10.1155/2020/3136074] [Reference Citation Analysis]
51 Burke MJ, Rheingold SR. Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia. Leukemia & Lymphoma 2016;58:540-51. [DOI: 10.1080/10428194.2016.1213826] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
52 Pizarro MD, Mamprin ME, Daurelio LD, Rodriguez JV, Mediavilla MG. Experimental bio-artificial liver: Importance of the architectural design on ammonia detoxification performance. World J Hepatol 2018; 10(10): 719-730 [PMID: 30386465 DOI: 10.4254/wjh.v10.i10.719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]